首页 > 最新文献

Cerebrovascular Diseases Extra最新文献

英文 中文
Emergency Department Workflow Times of Intravenous Thrombolysis with Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Prospective Cohort Study before and during the COVID-19 Pandemic. 急诊用替奈普酶静脉溶栓与阿替普酶治疗急性缺血性卒中的工作时间:一项2019冠状病毒病大流行之前和期间的前瞻性队列研究
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-02-03 DOI: 10.1159/000543900
Matias Guzman, Pablo M Lavados, Gabriel Cavada, Alejandro M Brunser, Veronica V Olavarria
<p><strong>Introduction: </strong>Tenecteplase (TNK) has demonstrated to be non-inferior to alteplase (ALT) for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). There are potential workflow benefits associated with TNK use, aiming to reduce patient length of stay in the emergency department. Our aim was to investigate whether the routine use of TNK during the COVID-19 pandemic influenced workflow times compared to historical use of ALT, while maintaining non-inferior clinical outcomes in a non-drip and ship scenario of a comprehensive stroke center.</p><p><strong>Methods: </strong>We included patients with AIS admitted from September 2019 to September 2022 and compared those treated with TNK during the COVID-19 pandemic to those treated with ALT in the period immediately before. We compared emergency department length of stay (EDLOS), door-to-needle time (DTN), door-to-groin puncture time (DTG), clinical and safety outcomes with adjusted general linear regression models.</p><p><strong>Results: </strong>110 patients treated with TNK and 111 with ALT were included in this study. Mean EDLOS was 251 (SD = 164) min for TNK users versus 240 (SD = 148) min for ALT (p = 0.62). Mean DTN was 43 (SD = 25) min for TNK versus 46 (SD = 27) min for ALT users (p = 0.39). Mean DTN under 60 min was achieved in 86 (78.2%) patients and in 85 (76.5%) patients of the TNK and ALT groups, respectively (p = 1.0). DTN under 45 min was achieved in 65.4% and 58.6% (p = 0.65) of the TNK and ALT groups, respectively. DTG time was 114 (SD = 43) min for TNK versus 111 (58 = SD) min in the ALT group (p = 0.88). DTG under 90 min was achieved in 32% of the TNK group and 35% of the ALT group (p = 0.69). There were no differences in any of the clinical or safety outcomes between groups at 90 days.</p><p><strong>Conclusions: </strong>The adoption of TNK during COVID-19 pandemic did not result in a change in EDLOS, DTN, or DTG times when compared to ALT in this cohort. Safety and clinical outcomes were similar between groups. Probably a greater benefit could have been seen in a drip and ship thrombolysis setting. Further research is needed to assess the potential advantages of TNK in drip and ship scenarios of IVT.</p><p><strong>Introduction: </strong>Tenecteplase (TNK) has demonstrated to be non-inferior to alteplase (ALT) for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). There are potential workflow benefits associated with TNK use, aiming to reduce patient length of stay in the emergency department. Our aim was to investigate whether the routine use of TNK during the COVID-19 pandemic influenced workflow times compared to historical use of ALT, while maintaining non-inferior clinical outcomes in a non-drip and ship scenario of a comprehensive stroke center.</p><p><strong>Methods: </strong>We included patients with AIS admitted from September 2019 to September 2022 and compared those treated with TNK during the COVID-19 pandemic to those treated with A
在急性缺血性卒中(AIS)的静脉溶栓(IVT)治疗中,Tenecteplase (TNK)已被证明优于阿替普酶(ALT)。使用TNK有潜在的工作流程优势,旨在减少患者在急诊科的住院时间。我们的目的是调查在COVID-19大流行期间,与历史上使用ALT相比,常规使用TNK是否会影响工作时间,同时在综合卒中中心的非点滴和船舶场景中保持非差的临床结果。方法:我们纳入2019年9月至2022年9月入院的AIS患者,并将COVID-19大流行期间接受TNK治疗的患者与之前接受ALT治疗的患者进行比较。我们比较急诊科住院时间(EDLOS)、门到针时间(DTN)、门到腹股沟穿刺时间(DTG)、临床和安全结果与调整后的一般线性回归模型。结果:110例患者接受TNK治疗,111例患者接受ALT治疗。TNK患者的平均EDLOS为251 (SD=164)分钟,ALT患者为240 (SD=148)分钟(p=0.62)。TNK组的平均DTN为43 (SD=25)分钟,ALT组为46 (SD=27)分钟(p=0.39)。TNK组和ALT组60分钟内平均DTN分别为86例(78.2%)和85例(76.5%)(p=1.0)。TNK组和ALT组45分钟内DTN分别达到65.4%和58.6% (p=0.65)。TNK组的DTG时间为114 (SD=43)分钟,ALT组为111 (58=SD)分钟(p=0.88)。TNK组和ALT组在90分钟内达到DTG的比例分别为32%和35% (p=0.69)。在90天时,两组之间的任何临床或安全性结果均无差异。结论:在该队列中,与ALT相比,在COVID - 19大流行期间采用TNK并未导致EDLOS、DTN或DTG时间的变化。两组间的安全性和临床结果相似。也许在点滴溶栓和船溶栓中可以看到更大的益处。需要进一步的研究来评估TNK在IVT滴注和船载方案中的潜在优势。
{"title":"Emergency Department Workflow Times of Intravenous Thrombolysis with Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Prospective Cohort Study before and during the COVID-19 Pandemic.","authors":"Matias Guzman, Pablo M Lavados, Gabriel Cavada, Alejandro M Brunser, Veronica V Olavarria","doi":"10.1159/000543900","DOIUrl":"10.1159/000543900","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Tenecteplase (TNK) has demonstrated to be non-inferior to alteplase (ALT) for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). There are potential workflow benefits associated with TNK use, aiming to reduce patient length of stay in the emergency department. Our aim was to investigate whether the routine use of TNK during the COVID-19 pandemic influenced workflow times compared to historical use of ALT, while maintaining non-inferior clinical outcomes in a non-drip and ship scenario of a comprehensive stroke center.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We included patients with AIS admitted from September 2019 to September 2022 and compared those treated with TNK during the COVID-19 pandemic to those treated with ALT in the period immediately before. We compared emergency department length of stay (EDLOS), door-to-needle time (DTN), door-to-groin puncture time (DTG), clinical and safety outcomes with adjusted general linear regression models.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;110 patients treated with TNK and 111 with ALT were included in this study. Mean EDLOS was 251 (SD = 164) min for TNK users versus 240 (SD = 148) min for ALT (p = 0.62). Mean DTN was 43 (SD = 25) min for TNK versus 46 (SD = 27) min for ALT users (p = 0.39). Mean DTN under 60 min was achieved in 86 (78.2%) patients and in 85 (76.5%) patients of the TNK and ALT groups, respectively (p = 1.0). DTN under 45 min was achieved in 65.4% and 58.6% (p = 0.65) of the TNK and ALT groups, respectively. DTG time was 114 (SD = 43) min for TNK versus 111 (58 = SD) min in the ALT group (p = 0.88). DTG under 90 min was achieved in 32% of the TNK group and 35% of the ALT group (p = 0.69). There were no differences in any of the clinical or safety outcomes between groups at 90 days.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The adoption of TNK during COVID-19 pandemic did not result in a change in EDLOS, DTN, or DTG times when compared to ALT in this cohort. Safety and clinical outcomes were similar between groups. Probably a greater benefit could have been seen in a drip and ship thrombolysis setting. Further research is needed to assess the potential advantages of TNK in drip and ship scenarios of IVT.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Tenecteplase (TNK) has demonstrated to be non-inferior to alteplase (ALT) for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). There are potential workflow benefits associated with TNK use, aiming to reduce patient length of stay in the emergency department. Our aim was to investigate whether the routine use of TNK during the COVID-19 pandemic influenced workflow times compared to historical use of ALT, while maintaining non-inferior clinical outcomes in a non-drip and ship scenario of a comprehensive stroke center.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We included patients with AIS admitted from September 2019 to September 2022 and compared those treated with TNK during the COVID-19 pandemic to those treated with A","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"102-109"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11882161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143123863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Waveform Analysis of STA-MCA Bypass graft in Revascularization Surgery for Moyamoya Disease. 莫亚莫亚氏病血管重建手术中的 STA-MCA 旁路移植波形分析。
IF 1.9 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-03-28 DOI: 10.1159/000538548
Ryuzaburo Kochi, Atsushi Kanoke, Ryosuke Tashiro, Hiroki Uchida, Hidenori Endo

Background: Postoperative hyperperfusion syndrome (PHS) is a well-known complication following superficial temporal artery (STA)-middle cerebral artery (MCA) bypass for moyamoya disease (MMD). The early detection of postoperative radiological hyperperfusion (PRH), characterized by a transient increase in local cerebral blood flow (CBF), is crucial for the early diagnosis of PHS. This study aimed to investigate the effectiveness of waveform analysis for early PRH detection.

Methods: We reviewed 52 consecutive patients who underwent STA-MCA bypass for MMD. Patients were divided into PRH and non-PRH groups based on the postoperative/preoperative CBF ratio. We collected the intraoperative bypass graft waveform and bypass flow data using a flowmeter. The pulsatile index (PI), an indicator of peripheral vascular resistance (PVR), was calculated from bypass flow data. Next, the newly proposed index of PVR, the ratio of the time from peak to 50% decay and to 100% decay (RT50), was calculated through waveform analysis. The values were then compared between the PRH and non-PRH groups.

Results: Twenty-seven of the 52 patients met the inclusion criteria. Fourteen of these 27 patients showed PRH. The RT50, but not the PI, was significantly higher in the PRH group. Linear regression analysis revealed a significant correlation between the RT50 and PI. In the receiver operating characteristic for predicting PRH, the area under the curve of RT50 was 0.750, with a cutoff value of 0.255, a sensitivity of 0.928, and a specificity of 0.500.

Conclusions: The RT50 obtained from waveform analysis is associated with PVR and can be useful for the early detection of PRH in patients with MMD.

背景:术后高灌注综合征(PHS)是众所周知的颞浅动脉(STA)-大脑中动脉(MCA)搭桥术治疗莫亚莫亚病(MMD)的并发症。术后放射学高灌注(PRH)的特征是局部脑血流(CBF)的短暂增加,早期发现PRH对于PHS的早期诊断至关重要。本研究旨在探讨波形分析在早期检测 PRH 方面的有效性:方法:我们回顾了 52 例连续接受 STA-MCA 分流治疗 MMD 的患者。根据术后/术前 CBF 比值将患者分为 PRH 组和非 PRH 组。我们使用流量计收集了术中旁路移植波形和旁路血流数据。根据旁路血流数据计算出外周血管阻力(PVR)指标--搏动指数(PI)。接着,通过波形分析计算出新提出的 PVR 指数,即从峰值到 50%衰减和到 100% 衰减的时间之比(RT50)。然后对 PRH 组和非 PRH 组的数值进行比较:52 名患者中有 27 名符合纳入标准。结果:52 名患者中有 27 人符合纳入标准,其中 14 人表现为 PRH。PRH 组的 RT50 值明显高于非 PRH 组。线性回归分析显示,RT50 和 PI 之间存在明显的相关性。在预测 PRH 的接收器操作特征中,RT50 的曲线下面积为 0.750,临界值为 0.255,灵敏度为 0.928,特异性为 0.500:通过波形分析获得的 RT50 与 PVR 相关,可用于 MMD 患者 PRH 的早期检测。
{"title":"Waveform Analysis of STA-MCA Bypass graft in Revascularization Surgery for Moyamoya Disease.","authors":"Ryuzaburo Kochi, Atsushi Kanoke, Ryosuke Tashiro, Hiroki Uchida, Hidenori Endo","doi":"10.1159/000538548","DOIUrl":"10.1159/000538548","url":null,"abstract":"<p><strong>Background: </strong>Postoperative hyperperfusion syndrome (PHS) is a well-known complication following superficial temporal artery (STA)-middle cerebral artery (MCA) bypass for moyamoya disease (MMD). The early detection of postoperative radiological hyperperfusion (PRH), characterized by a transient increase in local cerebral blood flow (CBF), is crucial for the early diagnosis of PHS. This study aimed to investigate the effectiveness of waveform analysis for early PRH detection.</p><p><strong>Methods: </strong>We reviewed 52 consecutive patients who underwent STA-MCA bypass for MMD. Patients were divided into PRH and non-PRH groups based on the postoperative/preoperative CBF ratio. We collected the intraoperative bypass graft waveform and bypass flow data using a flowmeter. The pulsatile index (PI), an indicator of peripheral vascular resistance (PVR), was calculated from bypass flow data. Next, the newly proposed index of PVR, the ratio of the time from peak to 50% decay and to 100% decay (RT50), was calculated through waveform analysis. The values were then compared between the PRH and non-PRH groups.</p><p><strong>Results: </strong>Twenty-seven of the 52 patients met the inclusion criteria. Fourteen of these 27 patients showed PRH. The RT50, but not the PI, was significantly higher in the PRH group. Linear regression analysis revealed a significant correlation between the RT50 and PI. In the receiver operating characteristic for predicting PRH, the area under the curve of RT50 was 0.750, with a cutoff value of 0.255, a sensitivity of 0.928, and a specificity of 0.500.</p><p><strong>Conclusions: </strong>The RT50 obtained from waveform analysis is associated with PVR and can be useful for the early detection of PRH in patients with MMD.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11037892/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors for Adherence to Recommended Anticoagulation after Stroke Unit Discharge in Patients with Atrial Fibrillation. 心房颤动患者卒中单元出院后坚持建议抗凝治疗的预测因素。
IF 1.9 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-02-12 DOI: 10.1159/000537781
Theresa Frank, Jens Neumann, Anne Assmann, Stefanie Schreiber, Aiden Haghikia, Maria Barleben, Michael Sailer, Michael Goertler
<p><strong>Introduction: </strong>Non-adherence to recommended secondary preventive anticoagulation in stroke patients with atrial fibrillation (AF) is a common phenomenon although the introduction of direct oral anticoagulants (DOACs) has simplified anticoagulation management for physicians as well as for patients.</p><p><strong>Methods: </strong>We examined the adherence of secondary preventive anticoagulation in AF patients after re-integration in their social environment 6 to 12 weeks after stroke unit and rehabilitation clinic treatment and analyzed for predictors for adherence and non-adherence. We conducted a telephone survey in consecutive patients treated between January 2013 and December 2021 at our institutional stroke unit with an acute cerebrovascular ischemic event and we analyzed discharge letters of rehabilitation clinics of those patients not anticoagulated at follow-up. All patients had known or newly diagnosed AF and in all we had recommended secondary preventive anticoagulation.</p><p><strong>Results: </strong>Follow-up information about anticoagulant intake could be obtained in 1348 of 1685 patients (80.0%) treated within the study period. Anticoagulation rate was 91.5% with 83.6% of patients receiving DOACs and 7.9% receiving vitamin K antagonists (VKAs). Adherence to recommended anticoagulation was associated with intake of the recommended anticoagulant already at discharge (adjusted OR, 18.357; CI, 9.637 to 34.969), recommendation of a specific DOAC and dose (in contrast to "DOAC" as drug category) (adjusted OR, 2.971; CI, 1.173 to 7.255), a lower modified Rankin Scale at discharge (per point; adjusted OR, 0.813; CI, 0.663 to 0.996), younger age (per year; adjusted odds ratio [OR], 0.951; confidence interval [CI], 0.926 to 0.976), and the absence of peripheral vascular disease (adjusted OR, 0.359; CI, 0.173 to 0.746). In patients already anticoagulated at discharge adherence was 98.5%, irrespective of a patient's age, functional deficit at discharge, and peripheral vascular disease. Avoidable obstacles for non-adherence in patients not on anticoagulants at stroke unit discharge were (1) non-implementation of recommended anticoagulation by rehabilitation physicians predominantly in patients with moderate-severe or severe stroke disability (2.1%), (2) delegation of anticoagulation start from rehabilitation physicians to general practitioners/resident radiologists (1.3%), and (3) rejection of recommended anticoagulation because of patients' severe stroke disability (0.5%). Non-avoidable obstacles were contraindications to anticoagulation (2.1%) and patients' refusal (0.7%).</p><p><strong>Conclusions: </strong>Commencing drug administration already during stroke unit hospitalization and providing an explanation for the selection of the recommended anticoagulant in discharge letters ensures high adherence at patients' re-integration in their social environment after acute stroke treatment. If drug administration cannot be comme
导言:尽管直接口服抗凝药(DOACs)的引入简化了医生和患者的抗凝管理,但中风房颤(AF)患者不坚持推荐的二级预防性抗凝治疗是一个普遍现象:我们研究了房颤患者在卒中单元和康复诊所治疗 6 至 12 周后重新融入社会环境后的二级预防性抗凝治疗依从性,并分析了依从和不依从的预测因素。我们对 2013 年 1 月至 2021 年 12 月期间在本院卒中单元接受急性脑血管缺血性事件治疗的连续患者进行了电话调查,并对随访时未进行抗凝治疗的患者的康复诊所出院信进行了分析。所有患者都有已知或新诊断的房颤,我们都建议他们进行二级预防性抗凝治疗:在研究期间接受治疗的 1685 名患者中,有 1348 人(80.0%)获得了服用抗凝剂的随访信息。抗凝率为 91.5%,其中 83.6% 的患者服用 DOAC,7.9% 的患者服用维生素 K 拮抗剂 (VKAs)。坚持推荐的抗凝治疗与以下因素有关:出院时已摄入推荐的抗凝剂(调整 OR,18.357;CI,9.637 至 34.969);推荐特定的 DOAC 和剂量(与作为药物类别的 "DOAC "相反)(调整 OR,2.971;CI,1.173 至 7.255);修改后的兰格氏评分较低。255)、出院时修改后的兰金量表较低(每点;调整后 OR,0.813;CI,0.663 至 0.996)、年龄较小(每年;调整后几率比 [OR],0.951;置信区间 [CI],0.926 至 0.976)以及无外周血管疾病(调整后 OR,0.359;CI,0.173 至 0.746)。在出院时已接受抗凝治疗的患者中,无论患者的年龄、出院时的功能缺陷和外周血管疾病如何,坚持治疗的比例均为 98.5%。卒中单元出院时未接受抗凝治疗的患者未坚持治疗的可避免障碍是:(1)康复科医生未执行建议的抗凝治疗,主要是中重度或重度卒中残疾患者(2.1%);(2)康复科医生将抗凝治疗的起始时间委托给全科医生/放射科住院医师(1.3%);(3)因患者严重卒中残疾而拒绝接受建议的抗凝治疗(0.5%)。不可避免的障碍是抗凝禁忌症(2.1%)和患者拒绝(0.7%):结论:在卒中单元住院期间就开始用药,并在出院信中说明选择推荐的抗凝药物,可确保患者在急性卒中治疗后重新融入社会环境时高度依从。如果不能在出院前开始用药,则应由卒中医生对康复医生进行教育,并让卒中医生参与到卒中后的决策过程中,这可能会减少可避免的障碍。
{"title":"Predictors for Adherence to Recommended Anticoagulation after Stroke Unit Discharge in Patients with Atrial Fibrillation.","authors":"Theresa Frank, Jens Neumann, Anne Assmann, Stefanie Schreiber, Aiden Haghikia, Maria Barleben, Michael Sailer, Michael Goertler","doi":"10.1159/000537781","DOIUrl":"10.1159/000537781","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Non-adherence to recommended secondary preventive anticoagulation in stroke patients with atrial fibrillation (AF) is a common phenomenon although the introduction of direct oral anticoagulants (DOACs) has simplified anticoagulation management for physicians as well as for patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We examined the adherence of secondary preventive anticoagulation in AF patients after re-integration in their social environment 6 to 12 weeks after stroke unit and rehabilitation clinic treatment and analyzed for predictors for adherence and non-adherence. We conducted a telephone survey in consecutive patients treated between January 2013 and December 2021 at our institutional stroke unit with an acute cerebrovascular ischemic event and we analyzed discharge letters of rehabilitation clinics of those patients not anticoagulated at follow-up. All patients had known or newly diagnosed AF and in all we had recommended secondary preventive anticoagulation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Follow-up information about anticoagulant intake could be obtained in 1348 of 1685 patients (80.0%) treated within the study period. Anticoagulation rate was 91.5% with 83.6% of patients receiving DOACs and 7.9% receiving vitamin K antagonists (VKAs). Adherence to recommended anticoagulation was associated with intake of the recommended anticoagulant already at discharge (adjusted OR, 18.357; CI, 9.637 to 34.969), recommendation of a specific DOAC and dose (in contrast to \"DOAC\" as drug category) (adjusted OR, 2.971; CI, 1.173 to 7.255), a lower modified Rankin Scale at discharge (per point; adjusted OR, 0.813; CI, 0.663 to 0.996), younger age (per year; adjusted odds ratio [OR], 0.951; confidence interval [CI], 0.926 to 0.976), and the absence of peripheral vascular disease (adjusted OR, 0.359; CI, 0.173 to 0.746). In patients already anticoagulated at discharge adherence was 98.5%, irrespective of a patient's age, functional deficit at discharge, and peripheral vascular disease. Avoidable obstacles for non-adherence in patients not on anticoagulants at stroke unit discharge were (1) non-implementation of recommended anticoagulation by rehabilitation physicians predominantly in patients with moderate-severe or severe stroke disability (2.1%), (2) delegation of anticoagulation start from rehabilitation physicians to general practitioners/resident radiologists (1.3%), and (3) rejection of recommended anticoagulation because of patients' severe stroke disability (0.5%). Non-avoidable obstacles were contraindications to anticoagulation (2.1%) and patients' refusal (0.7%).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Commencing drug administration already during stroke unit hospitalization and providing an explanation for the selection of the recommended anticoagulant in discharge letters ensures high adherence at patients' re-integration in their social environment after acute stroke treatment. If drug administration cannot be comme","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923591/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enlarged perivascular spaces predict malignant cerebral edema after acute large hemispheric infarction. 扩大的血管周围间隙预示着急性大面积脑梗塞后的恶性脑水肿。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-02-05 DOI: 10.1159/000536592
Yaxin Wei, Qingzi Zhang, Jinhui Niu, Jian Miao, Rui Ma, Kang Huo, Shaojun Wang

Introduction: Enlarged perivascular spaces (EPVS) are considered early manifestations of impaired clearance mechanisms in the brain; however, it is unclear whether EPVS they are associated with the development of malignant cerebral edema (MCE) after large hemispheric infarction (LHI). Therefore, we investigated the predictive value of EPVS in predicting MCE in LHI.

Methods: Patients suffering from acute LHI were consecutively enrolled. EPVS were rated after the stroke with validated rating scales from magnetic resonance imagess. Patients were divided into two groups according to the occurrence of MCE. Logistic regression was used to analyze the relationship between EPVS and MCE in the basal ganglia (BG) and centrum semiovale (CS) regions. Receiver operating characteristic (ROC) curves assessed the ability of EPVS individually and with other factors in predicting MCE.

Results: We included a total of 255 patients, of whom 98 were MCE patients (58 [59.2%] males, aged 70 [range=61.75-78] years) and found that atrial fibrillation, National Institutes of Health Stroke Scale score, infarct volume, neutrophil-lymphocyte ratio, and moderate-to-severe CS-EPVS were positively associated with MCE. After adjusting for confounds, moderate-to-severe CS-EPVS remained independent risk factor of MCE (odds ratio=16.212, p<0.001). According to the ROC analysis, MCE was highly suspected when CS-EPVS > 14 (sensitivity=0.82, specificity=0.48), and the guiding value were higher when CS-EPVS combined with other MCE predictors (area under the curve=0.90, sensitivity=0.74, specificity=0.90).

Conclusion: CS-EPVS were important risk factor for MEC in patients with acute LHI and can help identify patients at risk for MCE.

导言:血管周围间隙增大(EPVS)被认为是大脑清除机制受损的早期表现;然而,EPVS是否与大面积半球脑梗死(LHI)后恶性脑水肿(MCE)的发生相关尚不清楚。因此,我们研究了 EPVS 在预测 LHI 恶性脑水肿方面的预测价值:方法:连续招募急性 LHI 患者。方法:连续招募急性 LHI 患者,在卒中后使用有效的磁共振成像评分量表对 EPVS 进行评分。根据发生 MCE 的情况将患者分为两组。采用逻辑回归分析基底节(BG)和半卵圆中心(CS)区域 EPVS 与 MCE 之间的关系。受体操作特征曲线(ROC)评估了EPVS单独和与其他因素一起预测MCE的能力:我们共纳入了 255 名患者,其中 98 人为 MCE 患者(58 [59.2%] 名男性,年龄 70 [range=61.75-78] 岁),发现心房颤动、美国国立卫生研究院卒中量表评分、梗死体积、中性粒细胞-淋巴细胞比值和中重度 CS-EPVS 与 MCE 呈正相关。调整混杂因素后,中重度CS-EPVS仍是MCE的独立危险因素(几率比=16.212,P<0.001)。根据ROC分析,当CS-EPVS>14时,高度怀疑MCE(灵敏度=0.82,特异度=0.48),当CS-EPVS与其他MCE预测因素相结合时,指导值更高(曲线下面积=0.90,灵敏度=0.74,特异度=0.90):结论:CS-EPVS是急性LHI患者发生MCE的重要危险因素,有助于识别有发生MCE风险的患者。
{"title":"Enlarged perivascular spaces predict malignant cerebral edema after acute large hemispheric infarction.","authors":"Yaxin Wei, Qingzi Zhang, Jinhui Niu, Jian Miao, Rui Ma, Kang Huo, Shaojun Wang","doi":"10.1159/000536592","DOIUrl":"10.1159/000536592","url":null,"abstract":"<p><strong>Introduction: </strong>Enlarged perivascular spaces (EPVS) are considered early manifestations of impaired clearance mechanisms in the brain; however, it is unclear whether EPVS they are associated with the development of malignant cerebral edema (MCE) after large hemispheric infarction (LHI). Therefore, we investigated the predictive value of EPVS in predicting MCE in LHI.</p><p><strong>Methods: </strong>Patients suffering from acute LHI were consecutively enrolled. EPVS were rated after the stroke with validated rating scales from magnetic resonance imagess. Patients were divided into two groups according to the occurrence of MCE. Logistic regression was used to analyze the relationship between EPVS and MCE in the basal ganglia (BG) and centrum semiovale (CS) regions. Receiver operating characteristic (ROC) curves assessed the ability of EPVS individually and with other factors in predicting MCE.</p><p><strong>Results: </strong>We included a total of 255 patients, of whom 98 were MCE patients (58 [59.2%] males, aged 70 [range=61.75-78] years) and found that atrial fibrillation, National Institutes of Health Stroke Scale score, infarct volume, neutrophil-lymphocyte ratio, and moderate-to-severe CS-EPVS were positively associated with MCE. After adjusting for confounds, moderate-to-severe CS-EPVS remained independent risk factor of MCE (odds ratio=16.212, p<0.001). According to the ROC analysis, MCE was highly suspected when CS-EPVS > 14 (sensitivity=0.82, specificity=0.48), and the guiding value were higher when CS-EPVS combined with other MCE predictors (area under the curve=0.90, sensitivity=0.74, specificity=0.90).</p><p><strong>Conclusion: </strong>CS-EPVS were important risk factor for MEC in patients with acute LHI and can help identify patients at risk for MCE.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10927297/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139693192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Features and Treatment Outcomes in Patients in Their Twenties with Ischemic Moyamoya Disease. 20 多岁缺血性 moyamoya 病患者的临床特征和治疗效果。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-01-01 Epub Date: 2024-08-12 DOI: 10.1159/000540769
Yutaro Ono, Yosuke Akamatsu, Shizuka Araya, Ryouga Yamazaki, Shunrou Fujiwara, Kohei Chida, Masakazu Kobayashi, Takahiro Koji, Kazunori Terasaki, Kuniaki Ogasawara

Introduction: Revascularization surgery is recommended for all pediatric patients with moyamoya disease (MMD) with ischemic symptoms because the brains of such patients are still developing. By contrast, no clear guidelines for selective revascularization surgery in adult patients (30 years or more) with ischemic presentation have been established. Regarding the age of initial onset of ischemic MMD, patients in their 20s are at the bottom of the distribution and this age group may share features with both adult and pediatric patients. The present prospective study aimed to clarify the clinical features and treatment outcomes of patients in their 20s (younger patients) with ischemic MMD compared with patients aged 30-60 years (older patients).

Methods: While patients with misery perfusion in the symptomatic cerebral hemisphere on 15O-positron emission tomography underwent combined surgery including direct and indirect revascularizations in the first study period and indirect revascularization alone in the second study period, patients without misery perfusion in that hemisphere received pharmacotherapy alone through the two study periods. Cerebral angiography via arterial catheterization and neuropsychological testing were performed before and after surgery.

Results: During 12 years, 12 younger patients were included and comprised 6% of all adult patients (194 patients). The incidence of misery perfusion in the affected hemisphere was significantly higher in younger (12/12 [100%]) than in older patients (57/182 [31%]) (p < 0.0001). No difference in the incidence of cerebral hyperperfusion syndrome and postoperatively declined cognition was seen between younger (2/5 [40%] and 2/5 [40%], respectively) and older (11/36 [31%] and 15/36 [42%], respectively) cerebral hemispheres undergoing combined revascularization surgery. No difference in the incidence of postoperatively formed collateral flows feeding more than one-third of the middle cerebral artery cortical territory on angiograms and postoperatively improved cognition was seen between younger (9/10 [90%] and 6/10 [60%], respectively) and older (18/22 [83%] and 14/22 [64%], respectively) cerebral hemispheres undergoing indirect revascularization surgery alone.

Conclusion: Patients in their 20s with ischemic MMD always exhibit misery perfusion in the affected hemisphere, unlike older patients, and sometimes develop cerebral hyperperfusion syndrome after combined revascularization surgery, leading to cognitive decline, similar to older patients. Moreover, indirect revascularization surgery alone forms sufficient collateral circulation and restores cognitive function in patients in their 20s, similar to older patients.

导言:建议对所有出现缺血症状的儿童莫亚莫亚氏病(MMD)患者进行血管再通手术,因为这类患者的大脑仍在发育。相比之下,对于有缺血症状的成年患者(30 岁或以上),目前尚无明确的选择性血管再通手术指南。关于缺血性多发性硬化症的初次发病年龄,20 多岁的患者处于分布的末端,这一年龄组的患者可能与成人和儿童患者具有相同的特征。本前瞻性研究旨在明确20多岁缺血性多发性硬化症患者(年轻患者)与30-60岁患者(年长患者)相比的临床特征和治疗效果:方法:15O-正电子发射断层扫描显示有症状的大脑半球有错误灌注的患者在第一个研究阶段接受了包括直接和间接血管再通在内的联合手术,在第二个研究阶段仅接受了间接血管再通手术,而该半球无错误灌注的患者在两个研究阶段均仅接受了药物治疗。手术前后通过动脉导管进行脑血管造影并进行神经心理学测试:12年间,共有12名年轻患者被纳入研究,占所有成年患者(194人)的6%。年轻患者(12/12 [100%])患侧大脑半球灌注不良的发生率明显高于年长患者(57/182 [31%])(p <0.0001)。接受联合血管再通手术的大脑半球中,年轻患者(分别为2/5[40%]和2/5[40%])和年长患者(分别为11/36[31%]和15/36[42%])的脑高灌注综合征和术后认知能力下降的发生率没有差异。单独接受间接血管再通手术的年轻大脑半球(分别为9/10[90%]和6/10[60%])和年龄较大的大脑半球(分别为18/22[83%]和14/22[64%])在血管造影上术后形成的侧支血流供养大脑皮质中动脉区域三分之一以上的发生率和术后认知能力改善方面没有差异:结论:与老年患者不同,20 多岁的缺血性 MMD 患者总是表现为患侧大脑半球灌注不良,在联合血管再通手术后有时会出现大脑高灌注综合征,导致认知能力下降,这一点与老年患者相似。此外,单独的间接血管再通手术可形成足够的侧支循环,并恢复 20 多岁患者的认知功能,这一点与老年患者相似。
{"title":"Clinical Features and Treatment Outcomes in Patients in Their Twenties with Ischemic Moyamoya Disease.","authors":"Yutaro Ono, Yosuke Akamatsu, Shizuka Araya, Ryouga Yamazaki, Shunrou Fujiwara, Kohei Chida, Masakazu Kobayashi, Takahiro Koji, Kazunori Terasaki, Kuniaki Ogasawara","doi":"10.1159/000540769","DOIUrl":"10.1159/000540769","url":null,"abstract":"<p><strong>Introduction: </strong>Revascularization surgery is recommended for all pediatric patients with moyamoya disease (MMD) with ischemic symptoms because the brains of such patients are still developing. By contrast, no clear guidelines for selective revascularization surgery in adult patients (30 years or more) with ischemic presentation have been established. Regarding the age of initial onset of ischemic MMD, patients in their 20s are at the bottom of the distribution and this age group may share features with both adult and pediatric patients. The present prospective study aimed to clarify the clinical features and treatment outcomes of patients in their 20s (younger patients) with ischemic MMD compared with patients aged 30-60 years (older patients).</p><p><strong>Methods: </strong>While patients with misery perfusion in the symptomatic cerebral hemisphere on 15O-positron emission tomography underwent combined surgery including direct and indirect revascularizations in the first study period and indirect revascularization alone in the second study period, patients without misery perfusion in that hemisphere received pharmacotherapy alone through the two study periods. Cerebral angiography via arterial catheterization and neuropsychological testing were performed before and after surgery.</p><p><strong>Results: </strong>During 12 years, 12 younger patients were included and comprised 6% of all adult patients (194 patients). The incidence of misery perfusion in the affected hemisphere was significantly higher in younger (12/12 [100%]) than in older patients (57/182 [31%]) (p &lt; 0.0001). No difference in the incidence of cerebral hyperperfusion syndrome and postoperatively declined cognition was seen between younger (2/5 [40%] and 2/5 [40%], respectively) and older (11/36 [31%] and 15/36 [42%], respectively) cerebral hemispheres undergoing combined revascularization surgery. No difference in the incidence of postoperatively formed collateral flows feeding more than one-third of the middle cerebral artery cortical territory on angiograms and postoperatively improved cognition was seen between younger (9/10 [90%] and 6/10 [60%], respectively) and older (18/22 [83%] and 14/22 [64%], respectively) cerebral hemispheres undergoing indirect revascularization surgery alone.</p><p><strong>Conclusion: </strong>Patients in their 20s with ischemic MMD always exhibit misery perfusion in the affected hemisphere, unlike older patients, and sometimes develop cerebral hyperperfusion syndrome after combined revascularization surgery, leading to cognitive decline, similar to older patients. Moreover, indirect revascularization surgery alone forms sufficient collateral circulation and restores cognitive function in patients in their 20s, similar to older patients.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"105-115"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141972056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Profile of Stroke Chameleons Receiving Intravenous Thrombolysis: Insights from a Single-Center Experience. 接受静脉溶栓治疗的中风变色龙的临床概况:单中心经验的启示
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-01-01 Epub Date: 2024-11-13 DOI: 10.1159/000542502
Alejandro M Brunser, Pablo M Lavados, Paula Muñoz-Venturelli, Verónica V Olavarría, Eloy Mansilla, Gabriel Cavada, Maria Elena Trejo, Pablo E González

Introduction: In emergency rooms (ERs), 5% of patients experiencing an acute ischemic stroke (AIS) receive an alternative diagnosis; these cases are known as stroke chameleons (SC). The percentage of SC treated with intravenous thrombolysis (IVT) and the characteristics have not been well described. We aimed at investigating the variables associated with the probability receiving IVT.

Methods: In this prospective study, we included consecutive patients with SC admitted at the ER of Clínica Alemana between September 2014 and October 2023.

Results: Among 1,193 stroke patients; sixty-three (5.2%) corresponded to SC. Ten of these cases (15.8%, 95% CI: 8.8-26.8) were treated with IVT, mean door-to-needle (DTN) time of 85.7 (SD 35) min, median of 73.5 (IQR 62-113) min. SCs who underwent IVT were younger (p = 0.01), with higher NIHSS (p = 0.05). They presented more frequently with altered level of consciousness in the NIHSS (p = 0.01), language abnormities (p = 0.001), and dysarthria (p = 0.01). In multivariate analysis, none of the variables were significantly associated with IVT. A secondary analysis showed that only time to brain imaging was significantly associated with IVT (OR: 0.99; 95% CI: 0.98-0.99; p = 0.01).

Conclusions: Almost 1 out of every 7 SC could be treated with IVT but with a prolonged DTN time; the chance of being treated is associated with time to brain imaging.

Introduction: In emergency rooms (ERs), 5% of patients experiencing an acute ischemic stroke (AIS) receive an alternative diagnosis; these cases are known as stroke chameleons (SC). The percentage of SC treated with intravenous thrombolysis (IVT) and the characteristics have not been well described. We aimed at investigating the variables associated with the probability receiving IVT.

Methods: In this prospective study, we included consecutive patients with SC admitted at the ER of Clínica Alemana between September 2014 and October 2023.

Results: Among 1,193 stroke patients; sixty-three (5.2%) corresponded to SC. Ten of these cases (15.8%, 95% CI: 8.8-26.8) were treated with IVT, mean door-to-needle (DTN) time of 85.7 (SD 35) min, median of 73.5 (IQR 62-113) min. SCs who underwent IVT were younger (p = 0.01), with higher NIHSS (p = 0.05). They presented more frequently with altered level of consciousness in the NIHSS (p = 0.01), language abnormities (p = 0.001), and dysarthria (p = 0.01). In multivariate analysis, none of the variables were significantly associated with IVT. A secondary analysis showed that only time to brain imaging was significantly associated with IVT (OR: 0.99; 95% CI: 0.98-0.99; p = 0.01).

Conclusions: Almost 1 out of every 7 SC could be treated with IVT but with a prolonged DTN time; the chance of being treated is associated with time to brain imaging.

导言:在急诊室(ER)中,5% 的急性缺血性卒中(AIS)患者接受了其他诊断,这些病例被称为卒中变色龙(SC)。接受静脉溶栓(IVT)治疗的变色龙比例及其特征尚未得到很好的描述。我们旨在研究与接受静脉溶栓治疗的概率相关的变量:在这项前瞻性研究中,我们纳入了2014年9月至2023年10月期间在Clínica Alemana急诊室住院的连续SC患者:在 1193 名中风患者中,有 63 例(5.2%)符合 SC。其中10例(15.8%,95%CI 8.8-26.8)接受了静脉输液治疗,平均门到针时间(DTN)为85.7分钟(SD 35),中位数为73.5分钟(IQR 62-113)。接受静脉注射的 SC 年龄更小(P=0.01),NIHSS 值更高(P=0.05)。他们更常出现 NIHSS 意识水平改变(p=0.01)、语言异常(p=0.001)和构音障碍(p=0.01)。在多变量分析中,没有一个变量与 IVT 显著相关。二次分析表明,只有脑成像时间与 IVT 显著相关(OR:0.99;95%CI,0.98-0.99。
{"title":"Clinical Profile of Stroke Chameleons Receiving Intravenous Thrombolysis: Insights from a Single-Center Experience.","authors":"Alejandro M Brunser, Pablo M Lavados, Paula Muñoz-Venturelli, Verónica V Olavarría, Eloy Mansilla, Gabriel Cavada, Maria Elena Trejo, Pablo E González","doi":"10.1159/000542502","DOIUrl":"10.1159/000542502","url":null,"abstract":"<p><strong>Introduction: </strong>In emergency rooms (ERs), 5% of patients experiencing an acute ischemic stroke (AIS) receive an alternative diagnosis; these cases are known as stroke chameleons (SC). The percentage of SC treated with intravenous thrombolysis (IVT) and the characteristics have not been well described. We aimed at investigating the variables associated with the probability receiving IVT.</p><p><strong>Methods: </strong>In this prospective study, we included consecutive patients with SC admitted at the ER of Clínica Alemana between September 2014 and October 2023.</p><p><strong>Results: </strong>Among 1,193 stroke patients; sixty-three (5.2%) corresponded to SC. Ten of these cases (15.8%, 95% CI: 8.8-26.8) were treated with IVT, mean door-to-needle (DTN) time of 85.7 (SD 35) min, median of 73.5 (IQR 62-113) min. SCs who underwent IVT were younger (p = 0.01), with higher NIHSS (p = 0.05). They presented more frequently with altered level of consciousness in the NIHSS (p = 0.01), language abnormities (p = 0.001), and dysarthria (p = 0.01). In multivariate analysis, none of the variables were significantly associated with IVT. A secondary analysis showed that only time to brain imaging was significantly associated with IVT (OR: 0.99; 95% CI: 0.98-0.99; p = 0.01).</p><p><strong>Conclusions: </strong>Almost 1 out of every 7 SC could be treated with IVT but with a prolonged DTN time; the chance of being treated is associated with time to brain imaging.</p><p><strong>Introduction: </strong>In emergency rooms (ERs), 5% of patients experiencing an acute ischemic stroke (AIS) receive an alternative diagnosis; these cases are known as stroke chameleons (SC). The percentage of SC treated with intravenous thrombolysis (IVT) and the characteristics have not been well described. We aimed at investigating the variables associated with the probability receiving IVT.</p><p><strong>Methods: </strong>In this prospective study, we included consecutive patients with SC admitted at the ER of Clínica Alemana between September 2014 and October 2023.</p><p><strong>Results: </strong>Among 1,193 stroke patients; sixty-three (5.2%) corresponded to SC. Ten of these cases (15.8%, 95% CI: 8.8-26.8) were treated with IVT, mean door-to-needle (DTN) time of 85.7 (SD 35) min, median of 73.5 (IQR 62-113) min. SCs who underwent IVT were younger (p = 0.01), with higher NIHSS (p = 0.05). They presented more frequently with altered level of consciousness in the NIHSS (p = 0.01), language abnormities (p = 0.001), and dysarthria (p = 0.01). In multivariate analysis, none of the variables were significantly associated with IVT. A secondary analysis showed that only time to brain imaging was significantly associated with IVT (OR: 0.99; 95% CI: 0.98-0.99; p = 0.01).</p><p><strong>Conclusions: </strong>Almost 1 out of every 7 SC could be treated with IVT but with a prolonged DTN time; the chance of being treated is associated with time to brain imaging.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"193-197"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11650874/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticoagulation Adherence: Bridging the Gap between Acute Stroke Treatment and Long-Term Secondary Prevention. 坚持抗凝治疗:缩小急性中风治疗与长期二级预防之间的差距。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-01-01 Epub Date: 2024-08-12 DOI: 10.1159/000540805
Ian Eustace
{"title":"Anticoagulation Adherence: Bridging the Gap between Acute Stroke Treatment and Long-Term Secondary Prevention.","authors":"Ian Eustace","doi":"10.1159/000540805","DOIUrl":"10.1159/000540805","url":null,"abstract":"","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"101-104"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141972055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bites and Stings: Exotic Causes of Stroke in Asia. 咬伤和蛰伤:亚洲中风的外来病因。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-01-01 Epub Date: 2024-09-13 DOI: 10.1159/000541381
Udaya K Ranawaka

Background: Many unusual and fascinating causes of stroke are seen in Asia. Although rarely encountered in the Western world, such cases are seen not so infrequently by neurologists, physicians, and other healthcare workers in Asian countries. This article highlights some of these intriguing causes of stroke such as snakebite, scorpion stings, and bee and wasp stings.

Summary: Snakebite is a neglected tropical disease of global importance affecting over 5 million people each year, and scorpion stings and bee and wasp stings affect over a million people worldwide every year. Strokes due to these uncommon causes predominantly affect young males in their most productive years, and many victims die or remain with residual disability with significant socioeconomic consequences to the affected families and society. Both ischaemic and haemorrhagic strokes are seen, with ischaemic strokes being more common. Many unanswered questions remain regarding the pathophysiological mechanisms, clinical spectrum, and the natural history of stroke due to these causes. Antivenom is effective in snake envenoming, antivenom and prazosin are effective in scorpion envenoming, and treatment of anaphylaxis and allergy is recommended in systemic reactions due to bee or wasp stings. However, there are no treatment guidelines or expert recommendations to guide the management of stroke in these patients, and there are no data on the safety and efficacy of stroke-specific treatments such as antiplatelet therapy, thrombolysis or endovascular treatment.

Key messages: More research is clearly needed to unravel the complexities related to stroke following snakebite, scorpion envenoming, and bee and wasp stings, and to guide the development of optimal stroke treatment strategies in these unusual situations. Awareness of these exotic stroke aetiologies is important in early recognition and appropriate management of patients presenting with stroke symptoms in Asian countries, and in global travellers from the region. International collaborations would go a long way in improving our understanding of these rare but fascinating causes of stroke.

背景:亚洲有许多不寻常的、令人着迷的中风病因。虽然在西方世界很少遇到此类病例,但亚洲国家的神经科医生、内科医生和其他医护人员并不鲜见。摘要:蛇咬伤是一种被忽视的全球性热带疾病,每年影响 500 多万人,蝎子蜇伤、蜜蜂和黄蜂蜇伤每年影响全世界 100 多万人。这些罕见病因导致的脑卒中主要影响正值壮年的年轻男性,许多患者死亡或留下后遗症,给患者家庭和社会带来严重的社会经济后果。缺血性和出血性脑卒中均有发生,其中缺血性脑卒中更为常见。关于这些原因导致的中风的病理生理机制、临床表现和自然病史仍有许多未解之谜。抗蛇毒血清对蛇咬伤有效,抗蛇毒血清和哌唑嗪对蝎子咬伤有效,建议对蜜蜂或黄蜂蛰伤引起的全身反应进行过敏性休克和过敏治疗。然而,目前还没有治疗指南或专家建议来指导这些患者的中风治疗,也没有关于抗血小板治疗、溶栓或血管内治疗等中风特异性治疗的安全性和有效性的数据:关键信息:显然需要开展更多研究,以揭示蛇咬伤、蝎子咬伤、蜂蜇伤和黄蜂蜇伤后中风的复杂性,并指导制定这些异常情况下的最佳中风治疗策略。对这些异国卒中病因的认识对于早期识别和适当处理亚洲国家出现卒中症状的患者以及来自该地区的全球旅行者非常重要。国际合作将极大地提高我们对这些罕见但迷人的中风病因的认识。
{"title":"Bites and Stings: Exotic Causes of Stroke in Asia.","authors":"Udaya K Ranawaka","doi":"10.1159/000541381","DOIUrl":"10.1159/000541381","url":null,"abstract":"<p><strong>Background: </strong>Many unusual and fascinating causes of stroke are seen in Asia. Although rarely encountered in the Western world, such cases are seen not so infrequently by neurologists, physicians, and other healthcare workers in Asian countries. This article highlights some of these intriguing causes of stroke such as snakebite, scorpion stings, and bee and wasp stings.</p><p><strong>Summary: </strong>Snakebite is a neglected tropical disease of global importance affecting over 5 million people each year, and scorpion stings and bee and wasp stings affect over a million people worldwide every year. Strokes due to these uncommon causes predominantly affect young males in their most productive years, and many victims die or remain with residual disability with significant socioeconomic consequences to the affected families and society. Both ischaemic and haemorrhagic strokes are seen, with ischaemic strokes being more common. Many unanswered questions remain regarding the pathophysiological mechanisms, clinical spectrum, and the natural history of stroke due to these causes. Antivenom is effective in snake envenoming, antivenom and prazosin are effective in scorpion envenoming, and treatment of anaphylaxis and allergy is recommended in systemic reactions due to bee or wasp stings. However, there are no treatment guidelines or expert recommendations to guide the management of stroke in these patients, and there are no data on the safety and efficacy of stroke-specific treatments such as antiplatelet therapy, thrombolysis or endovascular treatment.</p><p><strong>Key messages: </strong>More research is clearly needed to unravel the complexities related to stroke following snakebite, scorpion envenoming, and bee and wasp stings, and to guide the development of optimal stroke treatment strategies in these unusual situations. Awareness of these exotic stroke aetiologies is important in early recognition and appropriate management of patients presenting with stroke symptoms in Asian countries, and in global travellers from the region. International collaborations would go a long way in improving our understanding of these rare but fascinating causes of stroke.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"141-147"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142298192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Near-Complete Reversal of Large Diffusion-Weighted Imaging Lesion after Thrombectomy: A Case Report and Literature Review. 血栓切除术后大型弥散加权成像病变近乎完全逆转:病例报告和文献综述。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-01-01 Epub Date: 2024-10-22 DOI: 10.1159/000541905
Huy Quang Dang, Trung Quoc Nguyen, Duc Nguyen Chiem, Tra Vu Son Le, Ryan Anh-Quang Nguyen, Huy Nguyen, Thang Huy Nguyen

Introduction: Diffusion-weighted imaging (DWI) plays a crucial role in acute ischemic stroke (AIS), as it is used to evaluate the ischemic lesions that are irreversibly damaged. The reversibility of DWI ischemic lesions has been noted in patients with AIS who undergo revascularization therapy. In addition, the occurrence of this phenomenon in large ischemic regions remains rare, particularly the near-complete reversal of large DWI lesion cases.

Case presentation: A 58-year-old male presented with a generalized tonic-clonic seizure. Emergent magnetic resonance imaging (MRI) revealed an extremely large infarction lesion in the right hemisphere with an Alberta Stroke Program Early Computed Tomographic Score (ASPECTS) value of 2 and occlusion of the terminal right internal carotid artery. The patient was immediately transferred to the Digital Subtraction Angiography (DSA) Unit for endovascular treatment with a stent retriever. After a rapid successful reperfusion with expanded treatment in cerebral infarction (eTICI) score of 3, the patient promptly recovered 24 h after the procedure. A brain MRI was repeated after 8 days of admission, and interestingly, the DWI lesion showed significant reversal. The modified Rankin scale (mRS) at discharge was 2 and 1 at 90-day follow-up, respectively.

Conclusions: Our case shows that the reversibility of DWI ischemic lesions can occur during the acute stroke phase, even in patients with extremely large regions, if rapid and successful reperfusion is achieved. The clinical implications of this phenomenon indicate that using DWI to evaluate the infarct core should be interpreted with caution.

导言弥散加权成像(DWI)在急性缺血性卒中(AIS)中起着至关重要的作用,因为它可用于评估不可逆转损伤的缺血性病灶。在接受血管重建治疗的 AIS 患者中,DWI 缺血性病变具有可逆性。此外,在大面积缺血区域出现这种现象仍属罕见,尤其是大面积 DWI 病变近乎完全逆转的病例:一名 58 岁的男性因全身强直-阵挛发作而就诊。急诊磁共振成像(MRI)显示,患者右侧大脑半球出现超大梗死病灶,阿尔伯塔省卒中项目早期计算机断层扫描评分(ASPECTS)值为 2,右侧颈内动脉末端闭塞。患者被立即转到数字减影血管造影(DSA)室,使用支架回取器进行血管内治疗。经过快速成功的再灌注,脑梗塞扩大治疗(eTICI)评分为 3 分,患者在术后 24 小时迅速康复。入院 8 天后复查了脑部磁共振成像,有趣的是,DWI 病变出现了明显逆转。出院时的改良兰金量表(mRS)评分为2分,90天随访时的评分为1分:我们的病例表明,在急性卒中阶段,如果快速、成功地实现再灌注,即使患者的病变区域非常大,DWI缺血性病变也会发生逆转。这一现象的临床意义表明,使用 DWI 评估梗死核心应慎重。
{"title":"Near-Complete Reversal of Large Diffusion-Weighted Imaging Lesion after Thrombectomy: A Case Report and Literature Review.","authors":"Huy Quang Dang, Trung Quoc Nguyen, Duc Nguyen Chiem, Tra Vu Son Le, Ryan Anh-Quang Nguyen, Huy Nguyen, Thang Huy Nguyen","doi":"10.1159/000541905","DOIUrl":"10.1159/000541905","url":null,"abstract":"<p><strong>Introduction: </strong>Diffusion-weighted imaging (DWI) plays a crucial role in acute ischemic stroke (AIS), as it is used to evaluate the ischemic lesions that are irreversibly damaged. The reversibility of DWI ischemic lesions has been noted in patients with AIS who undergo revascularization therapy. In addition, the occurrence of this phenomenon in large ischemic regions remains rare, particularly the near-complete reversal of large DWI lesion cases.</p><p><strong>Case presentation: </strong>A 58-year-old male presented with a generalized tonic-clonic seizure. Emergent magnetic resonance imaging (MRI) revealed an extremely large infarction lesion in the right hemisphere with an Alberta Stroke Program Early Computed Tomographic Score (ASPECTS) value of 2 and occlusion of the terminal right internal carotid artery. The patient was immediately transferred to the Digital Subtraction Angiography (DSA) Unit for endovascular treatment with a stent retriever. After a rapid successful reperfusion with expanded treatment in cerebral infarction (eTICI) score of 3, the patient promptly recovered 24 h after the procedure. A brain MRI was repeated after 8 days of admission, and interestingly, the DWI lesion showed significant reversal. The modified Rankin scale (mRS) at discharge was 2 and 1 at 90-day follow-up, respectively.</p><p><strong>Conclusions: </strong>Our case shows that the reversibility of DWI ischemic lesions can occur during the acute stroke phase, even in patients with extremely large regions, if rapid and successful reperfusion is achieved. The clinical implications of this phenomenon indicate that using DWI to evaluate the infarct core should be interpreted with caution.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"185-192"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604242/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142510132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
siLOXL2 Inhibits Endothelial Inflammatory Response and EndMT Induced by ox-LDL. siLOXL2 可抑制 Ox-LDL 诱导的内皮炎症反应和 EndMT。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-01-01 Epub Date: 2024-10-17 DOI: 10.1159/000541906
Jing Ma, Jia Ling, Rui Tong, Jiefen Guo, Zhongsheng Zhu

Introduction: Our research aimed to investigate the potential role and mechanism of lysyl oxidase (LOX)-like 2 (LOXL2) in atherosclerosis (AS) by using the human umbilical vein endothelial cells (HUVECs) stimulated by oxidized low-density lipoprotein (ox-LDL).

Methods: HUVECs were treated with ox-LDL at different concentrations (0, 10, 25, 50, and 100 μg/mL) and incubated for 24 h. The transfection efficacy of siLOXL2 was investigated by Western blot and real-time quantitative polymerase chain reaction (RT-qPCR). Cell migration, intracellular ROS measurement, oxidative stress, enzyme-linked immunosorbent assay, and adhesion assays were carried out to examine the ox-LDL-induced HUVECs injury. RT-qPCR and Western blot were used to determine gene and protein expression levels.

Results: LOXL2 protein expression increased in ox-LDL-induced endothelial cells (ECs). ox-LDL + siLOXL2 significantly inhibited the migration ability of HUVECs and reduced the expression of vascular endothelial growth factor A (VEGFA) and matrix metalloproteinase 9 gene expressions (all, p < 0.05). The ox-LDL + siLOXL2 significantly reduced intracellular ROS production and inhibited the expression of Malondialdehyde, whereas it markedly enhanced superoxide dismutase and catalase (all, p < 0.05). Supernatant levels of interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) were significantly attenuated by the ox-LDL + siLOXL2 treatment (all, p < 0.05). ox-LDL + siLOXL2 markedly suppressed the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 (all, p < 0.05). ox-LDL + siLOXL2 treatment remarkably reduced the expression of α-smooth muscle actin and vimentin, while increased CD31 and von Willebrand factor gene expression (all, p < 0.05).

Conclusion: LOXL2 silencing is protected against ox-LDL-induced EC dysfunction, and the mechanism may be related to the inhibition of the EndMT pathway.

导言:方法:用不同浓度(0、10、25、50和100 μg/mL)的氧化低密度脂蛋白(ox-LDL)处理人脐静脉内皮细胞(HUVECs)并培养24小时。通过 Western 印迹和 RT-qPCR 检测 siLOXL2 的转染效果。还进行了细胞迁移、细胞内 ROS 测量、氧化应激、ELISA 和粘附试验,以检测 ox-LDL 诱导的 HUVECs 损伤。采用 RT-qPCR 和 Western 印迹检测基因和蛋白表达水平:结果:LOXL2 蛋白在 ox-LDL 诱导的内皮细胞中表达增加。Ox-LDL+siLOXL2 能显著抑制 HUVECs 的迁移能力,降低血管内皮生长因子 A(VEGFA)和基质金属蛋白酶 9(MMP-9)基因的表达(均为 P <0.05)。ox-LDL+siLOXL2 能显著减少细胞内 ROS 的产生,抑制丙二醛(MDA)的表达,同时明显增强超氧化物歧化酶(SOD)和过氧化氢酶(CAT)(均为 P <0.05)。经 ox-LDL+siLOXL2 处理后,上清液中的白细胞介素-1β(IL-1β)、白细胞介素 6(IL-6)和肿瘤坏死因子α(TNF-α)水平明显降低(均为 P <0.05)。Ox-LDL+siLOXL2显著抑制了细胞间粘附分子-1(ICAM-1)和血管细胞粘附分子-1(VCAM-1)的表达(均为P <0.05)。Ox-LDL+siLOXL2处理显著降低了α-平滑肌肌动蛋白(α-SMA)和波形蛋白的表达,同时增加了CD31和von Willebrand因子(vWF)基因的表达(均为P <0.05):结论:沉默LOXL2可防止氧化-LDL诱导的内皮细胞功能障碍,其机制可能与抑制EndMT途径有关。
{"title":"siLOXL2 Inhibits Endothelial Inflammatory Response and EndMT Induced by ox-LDL.","authors":"Jing Ma, Jia Ling, Rui Tong, Jiefen Guo, Zhongsheng Zhu","doi":"10.1159/000541906","DOIUrl":"10.1159/000541906","url":null,"abstract":"<p><strong>Introduction: </strong>Our research aimed to investigate the potential role and mechanism of lysyl oxidase (LOX)-like 2 (LOXL2) in atherosclerosis (AS) by using the human umbilical vein endothelial cells (HUVECs) stimulated by oxidized low-density lipoprotein (ox-LDL).</p><p><strong>Methods: </strong>HUVECs were treated with ox-LDL at different concentrations (0, 10, 25, 50, and 100 μg/mL) and incubated for 24 h. The transfection efficacy of siLOXL2 was investigated by Western blot and real-time quantitative polymerase chain reaction (RT-qPCR). Cell migration, intracellular ROS measurement, oxidative stress, enzyme-linked immunosorbent assay, and adhesion assays were carried out to examine the ox-LDL-induced HUVECs injury. RT-qPCR and Western blot were used to determine gene and protein expression levels.</p><p><strong>Results: </strong>LOXL2 protein expression increased in ox-LDL-induced endothelial cells (ECs). ox-LDL + siLOXL2 significantly inhibited the migration ability of HUVECs and reduced the expression of vascular endothelial growth factor A (VEGFA) and matrix metalloproteinase 9 gene expressions (all, p < 0.05). The ox-LDL + siLOXL2 significantly reduced intracellular ROS production and inhibited the expression of Malondialdehyde, whereas it markedly enhanced superoxide dismutase and catalase (all, p < 0.05). Supernatant levels of interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) were significantly attenuated by the ox-LDL + siLOXL2 treatment (all, p < 0.05). ox-LDL + siLOXL2 markedly suppressed the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 (all, p < 0.05). ox-LDL + siLOXL2 treatment remarkably reduced the expression of α-smooth muscle actin and vimentin, while increased CD31 and von Willebrand factor gene expression (all, p < 0.05).</p><p><strong>Conclusion: </strong>LOXL2 silencing is protected against ox-LDL-induced EC dysfunction, and the mechanism may be related to the inhibition of the EndMT pathway.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"165-176"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554340/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142477264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cerebrovascular Diseases Extra
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1